Company intelligence / Profile preview

Port

Los Angeles, California, United Statespanynj.gov ↗

Ownership: Private
Development stage: Commercial

Overview

Port Therapeutics is developing a new class of biomedicines that can be activated at precise locations and times within the body. Their approach integrates advances in synthetic biology, cell engineering, and clinical imaging to create therapies with spatial control for targeted interventions. The goal is to address local disease problems with high precision and potency. The company was founded in 2021 and is headquartered in Los Angeles, California. No published clinical results yet.

Modalities: BiologicCell therapySynthetic biology-based therapy
Industry: Biotech

Beyond the preview

Go deeper on Port.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Port.

Explore the full profile